Ambev, identified on the stock market as ABEV3, finds itself at a crossroads, with analysts sharply divided over its future. Bank of America remains optimistic, forecasting a 38.4% gain with a target price of R$ 15.50, suggesting a significant undervaluation given the current trends. Conversely, XP Investimentos adopts a more cautious stance, reducing their rating […]
